CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function - Wikidata - awgldk - TriplyDB

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

http://www.wikidata.org/entity/Q36204706

about

MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis Targeting the CCL2-CCR2 signaling axis in cancer metastasis The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Apigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.Molecular Signatures of Human Regulatory T Cells in Colorectal Cancer and Polyps.Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.Genome-wide association study identifies two new susceptibility loci for colorectal cancer at 5q23.3 and 17q12 in Han Chinese.Ectopic expression of the chemokine CXCL17 in colon cancer cells Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer.Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2.CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis.The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case report.Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion.CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.Gut Microbiota, Inflammation, and Colorectal Cancer.The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells.Myeloid-derived suppressor cells and their role in pancreatic cancer.Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.Determinants of metastatic competency in colorectal cancer.The HPV16 E7 Oncoprotein Disrupts Dendritic Cell Function and Induces the Systemic Expansion of CD11b(+)Gr1(+) Cells in a Transgenic Mouse Model CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.Dietary Phenethyl Isothiocyanate Protects Mice from Colitis Associated Colon Cancer.Hypoxia-inducible factors: a central link between inflammation and cancer.LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.TREM-1 promotes intestinal tumorigenesis.Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade.G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.

P2860

Q26747339-3EC5F7E8-1279-4460-A017-00A89E7BAF74 Q26748194-07754DDC-7CEA-449F-86D3-F6F0D9E61039 Q26765184-016F043B-B6F4-4426-A3AB-E0CD1833A97A Q28388630-650CB1F4-C4DC-42DC-88C3-2C9D771F063D Q33602761-D71046A3-329E-4F3C-84A2-A600BDF6B521 Q33660069-E57F2958-3A1E-475B-96FB-D90B793E4880 Q33660646-B86576E9-2058-43AB-B193-97B7DFD180D9 Q33736438-2B9F2154-4B48-4C54-BAED-0E15736400A4 Q33842749-AEBD5E44-C8B5-4192-8DB8-597248C16C0C Q36545613-54F960F1-04D7-4A63-919B-763A342BBABB Q36707761-8C50C093-F7DB-43E6-8096-BAE47A9195CF Q36827259-1B75C34C-1584-45FA-A679-1F035A5B838C Q36962436-7246B23E-9D65-42AE-A7F8-83515BCFE10A Q37373125-712564EA-4202-4847-9E79-6B6C8E306776 Q37564748-0486C499-E8E0-4D3F-9282-14EB4BF7F9FB Q37651394-52FE1D4C-A2E8-4334-8499-255B83E5375B Q37696391-2A32C823-1973-4FBF-B18C-F7C77F9E3D07 Q38702891-100CE05F-99CB-4316-A3F4-AF87FF63EA3D Q38706890-E3BA1978-3170-404F-BB1C-C447281E2E84 Q38718943-B3365A51-FE45-4956-9FD9-7822A3248C2F Q38741840-61336D36-766B-462D-BA76-09BF6E3BF0D7 Q38763251-E5A3ABCE-F551-416A-A958-E7E5063C656C Q38820842-4128C79F-6A83-43E1-8CFD-0BC26F1B89FB Q38949434-6EC72B00-A8A2-4FCE-B5AB-942D7FB6AC28 Q38998427-FB30225F-708F-4762-9611-48F99859E9B1 Q39026957-4F24DA5A-9B9B-49D6-92F7-48A8DE5C32E5 Q39064350-A6A796E6-5E42-4AB9-90A8-D326FB0D9BA9 Q39085740-EE778EBE-8A72-4303-BF6F-6A1BE5A156F2 Q39538711-2E4D16A3-F445-4060-8D82-2877D9EA539A Q40619963-891EF8BE-C157-463C-BE3E-433B26257A54 Q40761860-CD2E59EC-6B4F-48AD-BF63-5F526A09C4AE Q41338881-9CB4ACFD-7B6E-472F-8471-F9E7DB792871 Q41660926-4AA4E6DA-9FFB-4C5F-821F-16A4E196148B Q41678975-380BD788-9690-4DC9-A86B-64FBE15AE93F Q41997200-5E27C73F-4440-4895-BAEE-835EF42294CF Q42375130-5361C49C-C49C-4CE4-825C-F392CCE87ABF Q47099561-4F05DF03-5187-46E3-95A7-0FD6D7397B3E Q47150917-271CFA28-A66F-4851-9AD3-73E2D5CE4256 Q47620768-AD0164C3-9305-44F2-AB93-20C6D00A507A Q47850555-AAA4B6E1-F1A3-451C-94DC-D8302AFE35FE

P2860

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

http://www.wikidata.org/entity/Q36204706

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@ast

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@en

type

label

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@ast

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@en

prefLabel

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@ast

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@en

P1433

Q36204706-BC4AE885-8652-40F8-B600-825EDECDE707

P1476

Q36204706-44EC40CA-226B-4803-9ACF-475E153B399F

P2093

Q36204706-308EF7ED-0D4F-4F16-AF9C-94911AEF893D

Q36204706-31BAB5CB-934A-48EC-9A49-E8E8220BFD69

Q36204706-31D1F8F8-57C1-456E-9C3C-30B887A44B3E

Q36204706-5F076DD8-C365-41E7-B5DD-1264880E64B1

Q36204706-A1EDF80B-720C-4DE6-BB15-4FDC4D2F4B43

Q36204706-A3149E8F-8DC3-4715-9AED-9DDCF0209884

Q36204706-CD459C52-F839-49EC-A593-E590A36DD920

Q36204706-F02C9CB3-6006-4A38-AC6A-6F1EC4AA37CA

P2860

Q36204706-01BFF3E5-0F2B-4677-AB4B-AA80EAC8A858

Q36204706-0F27D44F-B407-4B7F-86DD-4B80A994DA5D

Q36204706-1A6D16E8-1C3C-4E7E-88C8-4C25BDF6F7D3

Q36204706-249E733B-FBE4-4C40-8BA0-5AA2E8E79174

Q36204706-2A57D0A4-EC4B-4560-9A6C-572893862681

Q36204706-301668A7-3370-43A6-8350-5B892AD11935

Q36204706-3689E8CB-804B-46E5-9538-37EAF45055CF

Q36204706-406D0683-4DB6-4B20-AA66-8D3AD83C2720

Q36204706-41E259AB-C21A-4CDD-89A3-2C2F9253F0EC

Q36204706-4EB6EE29-145D-4B85-94B6-2151110CFD9E

P304

Q36204706-D01E581D-209E-4A26-BD53-D42A78BA3E5F

P31

Q36204706-17F81723-F2BA-498A-B167-214026DB77DB

P356

Q36204706-BAB08245-12B4-4A25-B296-50274C227458

P433

Q36204706-F8288F8D-4612-43EF-A642-C4B0BE5B7086

P478

Q36204706-0CF1744A-9CB2-4FD1-8D98-57790A7C1575

P50

Q36204706-B0759528-9C0D-4BE3-A4D0-F9BE8BC144BB

P577

Q36204706-B800ADA0-CCA8-4E80-AC8D-E73118B7A090

P5875

Q36204706-E375088D-5C60-447D-97EC-7CAFE53B9A41

P698

Q36204706-D2D57F52-2222-4056-A769-E23852F52C55

P932

Q36204706-092B7218-EF07-47E7-A859-BFCE16DED11E

P356

J.CELREP.2015.06.024

P1433

P1476

CCL2 Promotes Colorectal Carci ...... r Cell Population and Function

@en

P2093

Carey Ann Gallini

http://www.w3.org/2001/XMLSchema#string

Eunyoung Chun

http://www.w3.org/2001/XMLSchema#string

Genevieve Soucy

http://www.w3.org/2001/XMLSchema#string

Jonathan N Glickman

http://www.w3.org/2001/XMLSchema#string

Monia Michaud

http://www.w3.org/2001/XMLSchema#string

Robert Odze

http://www.w3.org/2001/XMLSchema#string

Sydney Lavoie

http://www.w3.org/2001/XMLSchema#string

Wendy S Garrett

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

The chemokine superfamily revisited

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

The blockade of immune checkpoints in cancer immunotherapy

Myeloid-derived suppressor cells as regulators of the immune system

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment

P304

244-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2015.06.024

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279808326

http://www.w3.org/2001/XMLSchema#string

P698

26146082

http://www.w3.org/2001/XMLSchema#string

P932

4620029

http://www.w3.org/2001/XMLSchema#string